Your Article Summary
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Novartis officially inaugurated the US's first ever large–scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina. The facility is a result of a partnership between Novartis and the US Department of Health and Human Services. It is the first of its kind in the United States and highlights an important milestone in efforts to improve influenza vaccine manufacturing technology in the US and enhance domestic pandemic preparedness.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca and Dako sign agreement to develop companion diagnostics for cancer treatments
AstraZeneca, 02/08/10
GEH and Exelon Sign Deal to Supply Cobalt-60
Imaging Economics, 02/05/10
BioMarin to Acquire LEAD Therapeutics
BioMarin, 02/05/10
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Comment Sought on Cancer Trials Database
HealthDataManagement, 02/09/10
Blood Mgmt. Firm to Buy Global Med
HealthDataManagement, 02/09/10
AstraZeneca and Dako sign agreement to develop companion diagnostics for cancer treatments
AstraZeneca, 02/08/10
Article Search
Sponsor


See All Messages (


